Lucentis and Throat irritation - a phase IV clinical study of FDA data

Summary:

Throat irritation is reported as a side effect among people who take Lucentis (ranibizumab), especially for people who are female, 50-59 old, also take Metformin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Throat irritation when taking Lucentis. It is created by eHealthMe based on reports of 25,577 people who have side effects when taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Throat irritation?

Throat irritation is found to be associated with 1,420 drugs and 1,504 conditions by eHealthMe. Check the latest studies of Throat irritation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

25,577 people reported to have side effects when taking Lucentis.
Among them, 24 people (0.09%) have Throat irritation.

Among these 24 people:

What is the gender of people who have Throat irritation when taking Lucentis? *

female: 80 %
male: 20 %

What is the age of people who have Throat irritation when taking Lucentis? *

What are other drugs people take besides Lucentis? *

What are other side effects people have besides Throat irritation? *

Oxygen Saturation Decreased: 13 people, 54.17%
Blood Pressure Diastolic Increased: 13 people, 54.17%
Neuralgia (pain in one or more nerves): 13 people, 54.17%
Periodontitis (inflammation of the tissue around the teeth): 13 people, 54.17%
Body Temperature Decreased: 13 people, 54.17%
Loose Tooth: 13 people, 54.17%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 54.17%
Blood Pressure Systolic Increased: 13 people, 54.17%
Localised Infection (infection at the single location): 13 people, 54.17%
Pain In Extremity: 13 people, 54.17%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 50.00%
Back Pain: 10 people, 41.67%
Age-Related Macular Degeneration: 3 people, 12.50%
Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 2 people, 8.33%
Stable Angina (a constant chest pain): 2 people, 8.33%
High Blood Cholesterol: 1 person, 4.17%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 4.17%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.17%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 4.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Throat irritation?

- Check whether Throat irritation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Throat irritation:

Throat irritation (1,420 drugs)

Browse all the conditions that are associated with Throat irritation:

Throat irritation (1,504 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.